Research & Development
Thermo Fisher Scientific unveils next generation CE-IVD marked TaqPath COVID-19 2.0 test to detect any viral mutations
22 June 2021 -

Science service company Thermo Fisher Scientific reported on Monday the availability of the new CE-IVD marked COVID-19 test, called the TaqPath COVID-19 Fast PCR Combo Kit 2.0, to produce accurate results even as the virus that causes COVID-19 continues to mutate.

The company added that the TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands its range of high-precision tests for the detection of active SARS-CoV-2 infections. The kit uses an advanced assay design that compensates for current and emerging variants by using a total of eight targets in three genomic regions of the virus.

According to the company, the TaqPath COVID-19 Fast PCR Combo Kit 2.0 test evaluates raw saliva directly with a processing time of two hours to enable widespread, high-frequency testing.

Thermo Fisher Scientific added that its first generation TaqPath COVID-19 CE-IVD RT PCR Kit and TaqPath COVID-19 Combo Kit, each using a different assay design, received the first CE-IVD certification and US FDA's Emergency Use Authorization from the US in March 2020.



Related Headlines